Target intelligence / Profile preview

Vaccinia virus-induced oncolysis

Molecular classification: Other

Overview

Vaccinia virus-induced oncolysis is a therapeutic approach using genetically engineered Vaccinia viruses to selectively infect and kill cancer cells, while also stimulating an anti-tumor immune response. This process involves the direct lysis of tumor cells, disruption of tumor vasculature, and activation of both innate and adaptive immunity to combat cancer.

Other names: Oncolytic Vaccinia virus therapyVaccinia virus oncolysis

Mechanism of action

Direct lysis of tumor cells; Induction of immunogenic cell death; Stimulation of innate and adaptive immune responses; Disruption of tumor vasculature

Biological functions

Direct oncolysis of tumor cellsDisruption of tumor vasculatureActivation of anti-tumor immunityRemodeling of the tumor microenvironment

Disease associations

Cancer

Safety considerations

Potential for systemic immune reactionsViral replication in non-target tissues (though generally designed to avoid this)

Biomarkers

Biomarkers related to immune activationBiomarkers related to tumor response

Beyond the preview

Go deeper on Vaccinia virus-induced oncolysis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vaccinia virus-induced oncolysis.

Explore the full profile